Drugs / AL-NCD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04203056 Background | Dec 2019 → Oct 2022 | schizoaffective depressive disorder, schizophrenia, schizophreniform disorder | University of California, Los Angeles | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL-NCD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04203056 ↗ |